G323-0529 Screening compound: N-cyclooctyl-1-({5-[(1E)-2-(furan-2-yl)ethenyl]-3-methyl-1,2-oxazol-4-yl}sulfonyl)piperidine-3-carboxamide

G323-0529 Screening compound: N-cyclooctyl-1-({5-[(1E)-2-(furan-2-yl)ethenyl]-3-methyl-1,2-oxazol-4-yl}sulfonyl)piperidine-3-carboxamide
G323-0529 Screening compound: N-cyclooctyl-1-({5-[(1E)-2-(furan-2-yl)ethenyl]-3-methyl-1,2-oxazol-4-yl}sulfonyl)piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G323-0529
N-cyclooctyl-1-({5-[(1E)-2-(furan-2-yl)ethenyl]-3-methyl-1,2-oxazol-4-yl}sulfonyl)piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G323-0529

Molecular Formula

C24H33N3O5S (C24 H33 N3 O5 S)

Compound Name

N-cyclooctyl-1-({5-[(1E)-2-(furan-2-yl)ethenyl]-3-methyl-1,2-oxazol-4-yl}sulfonyl)piperidine-3-carboxamide

IUPAC name

N-cyclooctyl-1-({5-[(1E)-2-(furan-2-yl)ethenyl]-3-methyl-12-oxazol-4-yl}sulfonyl)piperidine-3-carboxamide

SMILES

Cc1noc(/C=C/c2ccco2)c1S(N(CCC1)CC1C(NC1CCCCCCC1)=O)(=O)=O

InChI

InChI=1S/C24H33N3O5S/c1-18-23(22(32-26-18)14-13-21-12-8-16-31-21)33(29,30)27-15-7-9-19(17-27)24(28)25-20-10-5-3-2-4-6-11-20/h8,12-14,16,19-20H,2-7,9-11,15,17H2,1H3,(H,25,28)/t19-/m0/s1

InChI Key

QIBILEITNCOUHJ-IBGZPJMESA-N

MDL Number (MFCD)

MFCD14997543

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.61

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.741

Distribution Coefficient, logD

3.741

Water Solubility, LogSw

-3.86

Polar Surface Area

85.617

Acid Dissociation Constant (pKa)

13.75

Base Dissociation Constant (pKb)

0.17

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

58.30

G323-0529 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G323-0529 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G323-0529?
Check Price and Availability of G323-0529, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G323-0529 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G323-0529
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G323-0529
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G323-0529 available by request